| 54.69 Real-Time Quote |  -0.23 / -0.42%Today’s Change | 39.93 Today|||52-Week Range 58.41 | +10.89% Year-to-Date |
| US doctors paid $1bn by top drug companies May 22 / FT.com | Lilly Scraps Oncology Candidate - Analyst Blog May 13 / Zacks.com |
| Eli Lilly And Company Stock Buy Recommendation Reiterated (LLY) May 21 / TheStreet.com | Novo Nordisk / Lundbeck: drugs start working May 01 / FT.com |
| AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward May 16 / TheStreet.com | Investors: Look beyond Merck's patent loss May 01 / Money |
| Amgen to Set Up JV in China - Analyst Blog May 14 / Zacks.com | US pharma: spot the difference Apr 29 / FT.com |
| Big Cap Pharma Is Turning Up May 14 / StockTwits |
| Previous close | 54.92 |
| Today’s open | 54.67 |
| Day’s range | 54.67 - 55.30 |
| Volume | 1,876,265 |
| Average volume (3 months) | 5,101,043 |
| Market cap | $61.9B |
| Dividend yield | 3.58% |
| Earnings growth (last year) | -6.15% |
| Earnings growth (this year) | +15.51% |
| Earnings growth (next 5 years) | -1.20% |
| Revenue growth (last year) | -6.93% |
| P/E ratio | 13.1 |
| Price/Sales | 2.43 |
| Price/Book | 4.25 |
| Today’s change | Today’s % change | |
|---|---|---|
| ABTAbbott Laboratories | -0.16 | -0.42% |
| AZNAstraZeneca PLC | -0.37 | -0.71% |
| CELGCelgene Corp | +0.78 | +0.63% |
| NVONovo Nordisk A/S | -0.08 | -0.05% |
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | $1.00 |
| Annual revenue (last year) | $22.6B |
| Annual profit (last year) | $4.1B |
| Net profit margin | 18.09% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer, CFO & EVP-Global Services Derica W. Rice, MBA |
Vice President- Biotechnology Discovery Research Thomas F. Bumol, PhD |
Corporate headquarters Indianapolis, Indiana |
.
